However, an issue in the use of NGF as an overactive bladder biomarker is the fact that it can be elevated in other clinical conditions as well, such as painful bladder syndrome, urinary infections, urinary lithiasis, and bladder tumors (45, 46). The gene discussed is NGF; the disease is overactive bladder.